Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Abbvie Inc (ABBV)

Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 277,347,232
  • Shares Outstanding, K 1,765,868
  • Annual Sales, $ 54,318 M
  • Annual Income, $ 4,863 M
  • 60-Month Beta 0.61
  • Price/Sales 5.15
  • Price/Cash Flow 9.93
  • Price/Book 34.47
Trade ABBV with:

Options Overview Details

View History
  • Implied Volatility 20.59% ( +2.33%)
  • Historical Volatility 20.01%
  • IV Percentile 64%
  • IV Rank 36.19%
  • IV High 29.42% on 04/12/24
  • IV Low 15.58% on 09/01/23
  • Put/Call Vol Ratio 0.35
  • Today's Volume 18,926
  • Volume Avg (30-Day) 20,287
  • Put/Call OI Ratio 0.88
  • Today's Open Interest 327,507
  • Open Int (30-Day) 351,673

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 23 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate 3.06
  • Number of Estimates 11
  • High Estimate 3.11
  • Low Estimate 3.00
  • Prior Year 2.91
  • Growth Rate Est. (year over year) +5.15%

Price Performance

See More
Period Period Low Period High Performance
1-Month
153.95 +0.90%
on 05/28/24
166.49 -6.70%
on 05/17/24
-4.28 (-2.68%)
since 04/26/24
3-Month
153.95 +0.90%
on 05/28/24
182.89 -15.06%
on 03/12/24
-22.66 (-12.73%)
since 02/28/24
52-Week
130.96 +18.62%
on 06/28/23
182.89 -15.06%
on 03/12/24
+17.78 (+12.93%)
since 05/26/23

Most Recent Stories

More News
Down 14% from All-Time Highs, is This Dividend King a Buy on the Dip?

With a strong product portfolio, this growth and income stock is an excellent long-term investment.

ABBV : 155.34 (-1.10%)
$SPX : 5,306.04 (+0.02%)
Abbvie Stock: Is Wall Street Bullish or Bearish?

Although Abbvie stock has been lagging behind the broader market over the past year, Wall Street analysts are still moderately bullish about its outlook.

ABBV : 155.34 (-1.10%)
$SPX : 5,306.04 (+0.02%)
PPH : 88.88 (-1.10%)
Forget Nvidia, Buy This Magnificent Healthcare Stock Instead

AbbVie's returns haven't been great this year, but investors shouldn't overlook this promising growth stock.

NVDA : 1,139.01 (+6.98%)
ABBV : 155.34 (-1.10%)
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever

These dividend stocks are ideal for investors seeking long-term passive income.

ABBV : 155.34 (-1.10%)
LOW : 215.37 (+0.07%)
PSA : 270.49 (-0.70%)
Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:RENB),(NASDAQ:CYTO),(NYSE:PFE),(NYSE:ABBV) EQNX::TICKER_END

ONCY : 1.1000 (+0.92%)
ONC.TO : 1.49 (-2.61%)
RENB : 1.4700 (+3.52%)
CYTO : 1.6100 (-9.55%)
PFE : 28.30 (-2.01%)
ABBV : 155.34 (-1.10%)
Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032

ONCY : 1.1000 (+0.92%)
ONC.TO : 1.49 (-2.61%)
RENB : 1.4700 (+3.52%)
CYTO : 1.6100 (-9.55%)
PFE : 28.30 (-2.01%)
ABBV : 155.34 (-1.10%)
A Must-Own Stock for Any Portfolio

This company offers growth, high yield, and dividend growth.

ABBV : 155.34 (-1.10%)
2 Billion More Reasons to Buy AbbVie Stock

This pharma giant just made a smart strategic acquisition.

ABBV : 155.34 (-1.10%)
1 Wall Street Analyst Thinks AbbVie Stock Is Going to $200. Is It a Buy at Around $165?

Revenue growth during what should be a disastrous patent cliff is encouraging.

CERE : 41.00 (-0.80%)
ABBV : 155.34 (-1.10%)
10 Stocks to Build a Dividend Portfolio With

All 10 of these stocks pay reliable and growing dividends.

GOOGL : 176.40 (+0.81%)
GOOG : 178.02 (+0.96%)
HD : 328.70 (+1.11%)
KO : 61.82 (-0.29%)
CAT : 346.47 (-0.70%)
CVX : 159.04 (+0.82%)
V : 270.98 (-1.28%)
NEE : 77.53 (+1.20%)
ABBV : 155.34 (-1.10%)
PLD : 105.00 (+0.24%)
MSFT : 430.32 (+0.04%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Strengthening short term outlook on maintaining the current direction.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

AbbVie has become one of the top-most pharma companies after it acquired Allergan. The deal has transformed AbbVie's portfolio by lowering its dependence on Humira, its flagship product. AbbVie has one of the most popular cancer drugs in its portfolio, Imbruvica and its newest immunology drugs Skyrizi...

See More

Key Turning Points

3rd Resistance Point 158.88
2nd Resistance Point 157.61
1st Resistance Point 156.48
Last Price 155.34
1st Support Level 154.08
2nd Support Level 152.81
3rd Support Level 151.68

See More

52-Week High 182.89
Fibonacci 61.8% 163.05
Fibonacci 50% 156.93
Last Price 155.34
Fibonacci 38.2% 150.80
52-Week Low 130.96

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar